Clinical Trials List
Protocol NumberPTK16083111
2017-06-01 - 2018-06-01
Phase I
Terminated1
ICD-10G30
Alzheimer's disease
ICD-9331.0
Alzheimer's disease
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yi-Hsin Weng Division of Rehabilitation Medicine
- KuoLun Huang Division of Neurology
- 陸清松 Division of Rehabilitation Medicine
- Kun-Ju Lin Division of Nuclear Medicine
- 蕭穎聰 Division of Radiology
The Actual Total Number of Participants Enrolled
36 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
0 participants
